Search

Tate & Lyle PLC

Closed

SectorConsumer defensive

360 -1.42

Overview

Share price change

24h

Current

Min

353.8

Max

365

Key metrics

By Trading Economics

Income

78M

56M

Sales

63M

1B

P/E

Sector Avg

52.286

28.085

EPS

0.2

Dividend yield

5.45

Profit margin

5.469

Employees

5,000

EBITDA

95M

188M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+16.39% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

5.45%

3.68%

Market Stats

By TradingEconomics

Market Cap

-5.3M

1.6B

Previous open

361.42

Previous close

360

News Sentiment

By Acuity

32%

68%

38 / 147 Consumer defensive

Tate & Lyle PLC Chart

Past performance is not a reliable indicator of future results.

Related News

7 Jan 2026, 23:11 UTC

Earnings

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 Jan 2026, 22:55 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 Jan 2026, 21:39 UTC

Major Market Movers

Raytheon Down Following Trump Post Criticizing Company

7 Jan 2026, 20:13 UTC

Major Market Movers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 Jan 2026, 20:03 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 Jan 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 Jan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 Jan 2026, 23:42 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 Jan 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 Jan 2026, 23:29 UTC

Acquisitions, Mergers, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 Jan 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 Jan 2026, 22:46 UTC

Earnings

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 Jan 2026, 22:45 UTC

Earnings

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 Jan 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 Jan 2026, 22:42 UTC

Earnings

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 Jan 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 Jan 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 Jan 2026, 22:40 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 Jan 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 Jan 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 Jan 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 Jan 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 Jan 2026, 21:22 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 Jan 2026, 21:18 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 Jan 2026, 21:05 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 Jan 2026, 20:29 UTC

Acquisitions, Mergers, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 Jan 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 Jan 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 Jan 2026, 19:48 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Tate & Lyle PLC Forecast

Price Target

By TipRanks

16.39% upside

12 Months Forecast

Average 425.52 GBX  16.39%

High 500 GBX

Low 367.6 GBX

Based on 5 Wall Street analysts offering 12 month price targets forTate & Lyle PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

4

Hold

0

Sell

Sentiment

By Acuity

38 / 147 Consumer defensive

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Tate & Lyle PLC

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverage, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. The company operates through three segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and Primient. It offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; sweeteners, such as high fructose corn syrup and dextrose; industrial starches; acidulants; and corn gluten feed and meal and corn oil. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
help-icon Live chat